Cleaved/associated TLR3 represents the primary form of the signaling receptor

Journal of Immunology

Volumn 190, Issue 2, 2013, Pages 764-773

  Toscano, Florent ^a   Estornes, Yann ^a   Virard, François ^a   Garcia Cattaneo, Alejandra ^b   Pierrot, Audrey ^a   Vanbervliet, Béatrice ^a   Bonnin, Marc ^a   Ciancanelli, Michael J ^c   Zhang, Shen Ying ^c,d   Funami, Kenji ^e   Seya, Tsukasa ^e   Matsumoto, Misako ^e   Pin, Jean Jacques ^f   Casanova, Jean Laurent ^c,d,g   Renno, Toufic ^a   Lebecque, Serge ^a  

^a CENTRE LÉON BÉRARD   (France)

^b PSL RESEARCH UNIVERSITY   (France)

^c ROCKEFELLER UNIVERSITY   (United States)

^d IMAGINE INSTITUTE   (France)

^e HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f DENDRITICS SAS   (France)

^g HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED RNA; MONOCLONAL ANTIBODY; TOLL LIKE RECEPTOR 3;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DIMERIZATION; HUMAN; HUMAN CELL; LYSOSOME; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN DOMAIN; PROTEIN STABILITY; RNA BINDING; SIGNAL TRANSDUCTION; WILD TYPE;

BINDING SITES; CATHEPSINS; CELL LINE; GENE EXPRESSION PROFILING; GOLGI APPARATUS; HUMANS; LYSOSOMES; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN TRANSPORT; PROTEOLYSIS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 3;

EID: 84872178810     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1202173     Document Type: Article

References (39)

1. Kawai, T., and S. Akira. 2011. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34: 637-650.
2. Gay, N. J., and M. Gangloff. 2007. Structure and function of Toll receptors and their ligands. Annu. Rev. Biochem. 76: 141-165.
3. Barton, G. M., and J. C. Kagan. 2009. A cell biological view of Toll-like receptor function: regulation through compartmentalization. Nat. Rev. Immunol. 9: 535-542.
4. Limmon, G. V., M. Arredouani, K. L. McCann, R. A. Corn Minor, L. Kobzik, and F. Imani. 2008. Scavenger receptor class-A is a novel cell surface receptor for double-stranded RNA. FASEB J. 22: 159-167.
5. Barton, G. M., J. C. Kagan, and R. Medzhitov. 2006. Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat. Immunol. 7: 49-56.
6. Tabeta, K., K. Hoebe, E. M. Janssen, X. Du, P. Georgel, K. Crozat, S. Mudd, N. Mann, S. Sovath, J. Goode, et al. 2006. The Unc93b1 mutation 3d disrupts exogenous antigen presentation and signaling via Toll-like receptors 3, 7 and 9. Nat. Immunol. 7: 156-164.
7. Kim, Y.-M., M. M. Brinkmann, M.-E. Paquet, and H. L. Ploegh. 2008. UNC93B1 delivers nucleotide-sensing toll-like receptors to endolysosomes. Nature 452: 234-238.
8. Park, B., M. M. Brinkmann, E. Spooner, C. C. Lee, Y.-M. Kim, and H. L. Ploegh. 2008. Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9. Nat. Immunol. 9: 1407-1414.
9. Ewald, S. E., A. Engel, J. Lee, M. Wang, M. Bogyo, and G. M. Barton. 2011. Nucleic acid recognition by Toll-like receptors is coupled to stepwise processing by cathepsins and asparagine endopeptidase. J. Exp. Med. 208: 643-651.
10. Ewald, S. E., B. L. Lee, L. Lau, K. E. Wickliffe, G.-P. Shi, H. A. Chapman, and G. M. Barton. 2008. The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor. Nature 456: 658-662.
11. Alexopoulou, L., A. C. Holt, R. Medzhitov, and R. A. Flavell. 2001. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413: 732-738.
12. Casrouge, A., S.-Y. Zhang, C. Eidenschenk, E. Jouanguy, A. Puel, K. Yang, A. Alcais, C. Picard, N. Mahfoufi, N. Nicolas, et al. 2006. Herpes simplex virus encephalitis in human UNC-93B deficiency. Science 314: 308-312.
13. Zhang, S.-Y., E. Jouanguy, S. Ugolini, A. Smahi, G. Elain, P. Romero, D. Segal, V. Sancho-Shimizu, L. Lorenzo, A. Puel, et al. 2007. TLR3 deficiency in patients with herpes simplex encephalitis. Science 317: 1522-1527.
14. Guo, Y., M. Audry, M. Ciancanelli, L. Alsina, J. Azevedo, M. Herman, E. Anguiano, V. Sancho-Shimizu, L. Lorenzo, E. Pauwels, et al. 2011. Herpes simplex virus encephalitis in a patient with complete TLR3 deficiency: TLR3 is otherwise redundant in protective immunity. J. Exp. Med. 208: 2083-2098.
15. Matsumoto, M., H. Oshiumi, and T. Seya. 2011. Antiviral responses induced by the TLR3 pathway. Rev. Med. Virol. 21: 67-77.
16. Karikó, K., H. Ni, J. Capodici, M. Lamphier, and D. Weissman. 2004. mRNA is an endogenous ligand for Toll-like receptor 3. J. Biol. Chem. 279: 12542-12550.
17. Wang, Y., L. Liu, D. R. Davies, and D. M. Segal. 2010. Dimerization of Toll-like receptor 3 (TLR3) is required for ligand binding. J. Biol. Chem. 285: 36836-36841.
18. Bell, J. K., J. Askins, P. R. Hall, D. R. Davies, and D. M. Segal. 2006. The dsRNA binding site of human Toll-like receptor 3. Proc. Natl. Acad. Sci. USA 103: 8792-8797.
19. Liu, L., I. Botos, Y. Wang, J. N. Leonard, J. Shiloach, D. M. Segal, and D. R. Davies. 2008. Structural basis of toll-like receptor 3 signaling with double-stranded RNA. Science 320: 379-381.
20. Fukuda, K., T. Tsujita, M. Matsumoto, T. Seya, H. Sakiyama, F. Nishikawa, S. Nishikawa, and T. Hasegawa. 2006. Analysis of the interaction between human TLR3 ectodomain and nucleic acids. Nucleic Acids Symp. Ser. (Oxf) 50: 249-250.
21. Watanabe, T., T. Tokisue, T. Tsujita, M. Matsumoto, T. Seya, S. Nishikawa, T. Hasegawa, and K. Fukuda. 2007. N-terminal binding site in the human toll-like receptor 3 ectodomain. Nucleic Acids Symp. Ser. (Oxf) 51: 405-406.
22. Garcia-Cattaneo, A., F. X. Gobert, M. Müller, F. Toscano, M. Flores, A. Lescure, E. Del Nery, and P. Benaroch. 2012. Cleavage of Toll-like receptor 3 by cathepsins B and H is essential for signaling. Proc. Natl. Acad. Sci. USA 109: 9053-9058.
23. Takada, E., S. Okahira, M. Sasai, K. Funami, T. Seya, and M. Matsumoto. 2007. C-terminal LRRs of human Toll-like receptor 3 control receptor dimerization and signal transmission. Mol. Immunol. 44: 3633-3640.
24. Sun, J., K. E. Duffy, C. T. Ranjith-Kumar, J. Xiong, R. J. Lamb, J. Santos, H. Masarapu, M. Cunningham, A. Holzenburg, R. T. Sarisky, et al. 2006. Structural and functional analyses of the human Toll-like receptor 3. Role of glycosylation. J. Biol. Chem. 281: 11144-11151.
25. Kaiser, W. J., J. L. Kaufman, and M. K. Offermann. 2004. IFN-α sensitizes human umbilical vein endothelial cells to apoptosis induced by double-stranded RNA. J. Immunol. 172: 1699-1710.
26. Qi, R., D. Singh, and C. C. Kao. 2012. Proteolytic processing regulates Toll-like receptor 3 stability and endosomal localization. J. Biol. Chem. 287: 32617-32629.
27. Chockalingam, A., J. C. Brooks, J. L. Cameron, L. K. Blum, and C. A. Leifer. 2009. TLR9 traffics through the Golgi complex to localize to endolysosomes and respond to CpG DNA. Immunol. Cell Biol. 87: 209-217.
28. Bell, J. K., I. Botos, P. R. Hall, J. Askins, J. Shiloach, D. M. Segal, and D. R. Davies. 2005. The molecular structure of the Toll-like receptor 3 ligand-binding domain. Proc. Natl. Acad. Sci. USA 102: 10976-10980.
29. Choe, J., M. S. Kelker, and I. A. Wilson. 2005. Crystal structure of human toll-like receptor 3 (TLR3) ectodomain. Science 309: 581-585.
30. Ranjith-Kumar, C. T., W. Miller, J. Xiong, W. K. Russell, R. Lamb, J. Santos, K. E. Duffy, L. Cleveland, M. Park, K. Bhardwaj, et al. 2007. Biochemical and functional analyses of the human Toll-like receptor 3 ectodomain. J. Biol. Chem. 282: 7668-7678.
31. Botos, I., L. Liu, Y. Wang, D. M. Segal, and D. R. Davies. 2009. The toll-like receptor 3:dsRNA signaling complex. Biochim. Biophys. Acta 1789: 667-674.
32. Leifer, C. A., M. N. Kennedy, A. Mazzoni, C. Lee, M. J. Kruhlak, and D. M. Segal. 2004. TLR9 is localized in the endoplasmic reticulum prior to stimulation. J. Immunol. 173: 1179-1183.
33. Latz, E., A. Schoenemeyer, A. Visintin, K. A. Fitzgerald, B. G. Monks, C. F. Knetter, E. Lien, N. J. Nilsen, T. Espevik, and D. T. Golenbock. 2004. TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat. Immunol. 5: 190-198.
34. Kasperkovitz, P. V., M. L. Cardenas, and J. M. Vyas. 2010. TLR9 is actively recruited to Aspergillus fumigatus phagosomes and requires the N-terminal proteolytic cleavage domain for proper intracellular trafficking. J. Immunol. 185: 7614-7622.
35. Sepulveda, F. E., S. Maschalidi, R. Colisson, L. Heslop, C. Ghirelli, E. Sakka, A.-M. Lennon-Duménil, S. Amigorena, L. Cabanie, and B. Manoury. 2009. Critical role for asparagine endopeptidase in endocytic Toll-like receptor signaling in dendritic cells. Immunity 31: 737-748.
36. Manavalan, B., S. Basith, and S. Choi. 2011. Similar structures but different roles - an updated perspective on TLR structures. Front. Physiol. 2: 41.
37. de Bouteiller, O., E. Merck, U. A. Hasan, S. Hubac, B. Benguigui, G. Trinchieri, E. E. Bates, and C. Caux. 2005. Recognition of double-stranded RNA by human toll-like receptor 3 and downstream receptor signaling requires multimerization and an acidic pH. J. Biol. Chem. 280: 38133-38145.
38. Estornes, Y., F. Toscano, F. Virard, G. Jacquemin, A. Pierrot, B. Vanbervliet, M. Bonnin, N. Lalaoui, P. Mercier-Gouy, Y. Pachéco, et al. 2012. dsRNA induces apoptosis through an atypical death complex associating TLR3 to caspase-8. Cell Death Differ. 19: 1482-1494.
39. Li, Y., I. C. Berke, and Y. Modis. 2012. DNA binding to proteolytically activated TLR9 is sequence-independent and enhanced by DNA curvature. EMBO J. 31: 919-931.